Cambridge Investment Research Advisors’s Calamos Nasdaq-100 Structured Alt Protection ETF - March CPNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,365
Closed -$270K 4112
2025
Q4
$270K Sell
10,365
-9,060
-47% -$233K ﹤0.01% 3304
2025
Q3
$497K Hold
19,425
﹤0.01% 2689
2025
Q2
$487K Buy
+19,425
New +$477K ﹤0.01% 2570

Other funds holding CPNM

Cambridge Investment Research Advisors's CPNM Position: Q1 2026 in Review

Cambridge Investment Research Advisors sold out of Calamos Nasdaq-100 Structured Alt Protection ETF - March (CPNM) in Q1 2026, closing a stake of 10,365 shares — an estimated $270K sold.

Cambridge Investment Research Advisors first reported a position in CPNM in Q2 2025 and held it in 3 quarters. The position peaked at $497K in Q3 2025. 16 funds tracked by Wall St. Rank hold CPNM as of Q1 2026.

  • Cambridge Investment Research Advisors reported no remaining Calamos Nasdaq-100 Structured Alt Protection ETF - March position as of Q1 2026 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 10,365 Calamos Nasdaq-100 Structured Alt Protection ETF - March shares in Q1 2026, an estimated $270K.
  • Cambridge Investment Research Advisors first reported a position in Calamos Nasdaq-100 Structured Alt Protection ETF - March in Q2 2025 and held it in 3 quarters.
  • Cambridge Investment Research Advisors's Calamos Nasdaq-100 Structured Alt Protection ETF - March position peaked at $497K in Q3 2025.
  • 16 funds tracked by Wall St. Rank held Calamos Nasdaq-100 Structured Alt Protection ETF - March as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.